170 related articles for article (PubMed ID: 32795093)
1. Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration: Potential Relevance to COVID-19 Risk.
Nelson CP; Sama IE; Codd V; Webb TR; Ye S; Lang CC; Voors AA; Ng LL; Samani NJ
Circulation; 2020 Sep; 142(11):1117-1119. PubMed ID: 32795093
[No Abstract] [Full Text] [Related]
2. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.
Delanghe JR; Speeckaert MM; De Buyzere ML
Clin Chim Acta; 2020 Jun; 505():192-193. PubMed ID: 32220422
[No Abstract] [Full Text] [Related]
3. [Genetic and epigenetic variability, and the Covid-19 pandemic].
Rivera-Silva G
Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
[No Abstract] [Full Text] [Related]
4. Genetic predisposition models to COVID-19 infection.
Darbeheshti F; Rezaei N
Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
[No Abstract] [Full Text] [Related]
5. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
6. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.
Tsiambas E; Chrysovergis A; Papanikolaou V; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Patsouris E; Riziotis C; Paschopoulos M; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2839-2841. PubMed ID: 32691391
[No Abstract] [Full Text] [Related]
7. Kawasaki-like disease in children with COVID-19: A hypothesis.
Amirfakhryan H
Med Hypotheses; 2020 Oct; 143():110117. PubMed ID: 32721809
[TBL] [Abstract][Full Text] [Related]
8. Could angiotensin-converting enzyme 1
Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
[No Abstract] [Full Text] [Related]
9. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
Su S; Jiang S
Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
[No Abstract] [Full Text] [Related]
10. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
Alshahawey M; Raslan M; Sabri N
Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
[No Abstract] [Full Text] [Related]
11. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 infections are also affected by human ACE1 D/I polymorphism.
Delanghe JR; Speeckaert MM; De Buyzere ML
Clin Chem Lab Med; 2020 Jun; 58(7):1125-1126. PubMed ID: 32286246
[No Abstract] [Full Text] [Related]
14. ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population.
Pati A; Mahto H; Padhi S; Panda AK
Clin Chim Acta; 2020 Nov; 510():455-458. PubMed ID: 32791137
[TBL] [Abstract][Full Text] [Related]
15. Covid-19 infection and mortality: a physiologist's perspective enlightening clinical features and plausible interventional strategies.
Abassi ZA; Skorecki K; Heyman SN; Kinaneh S; Armaly Z
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1020-L1022. PubMed ID: 32207983
[No Abstract] [Full Text] [Related]
16. [Are there genetic variants that can modify the course of the COVID-19 pandemic?].
Azurmendi PJ
Medicina (B Aires); 2020; 80 Suppl 3():79-81. PubMed ID: 32658852
[No Abstract] [Full Text] [Related]
17. Angiotensin converting enzyme-2 as therapeutic target in COVID-19.
Roshanravan N; Ghaffari S; Hedayati M
Diabetes Metab Syndr; 2020; 14(4):637-639. PubMed ID: 32428864
[TBL] [Abstract][Full Text] [Related]
18. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
[No Abstract] [Full Text] [Related]
19. Covid-19 infection and the host genetic predisposition: does it exist?
Vašků A
Physiol Res; 2020 Jul; 69(3):511-514. PubMed ID: 32682363
[TBL] [Abstract][Full Text] [Related]
20. Preterm birth: Potential risk factor for greater COVID-19 severity?
Debevec T; Burtscher J; Millet GP
Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
